Chemical coupling as a potent strategy for preparation of targeted bacteriophage-derived gene nanocarriers into eukaryotic cells

Journal of Gene Medicine

Volumn 13, Issue 11, 2011, Pages 622-631

  Khalaj Kondori, Mohammad ^a   Sadeghizadeh, Majid ^a   Behmanesh, Mehrdad ^a   Saggio, Isabella ^b   Monaci, Paolo ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chemical coupling; Gene delivery; Phage mediated gene transfer; Targeting

Indexed keywords

GREEN FLUORESCENT PROTEIN; NANOCARRIER; TRANSFERRIN;

ARTICLE; BACTERIOPHAGE; CHEMICAL COUPLING; COUPLING FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BACTERIOPHAGE LAMBDA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE DOSAGE; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NANOPARTICLES; PROTEIN BINDING; RECEPTORS, VIRUS; TRANSFECTION; TRANSFERRIN; TRANSGENES;

EID: 82455186766     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1617     Document Type: Article

References (45)

1. Michael SI, Curiel DT. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther 1994; 1: 223-232.
2. Piersanti S, Cherubini G, Martina Y, et al. Mammalian cell transduction and internalization properties of lambda phage displaying the full-length adenoviral penton base or its central domain. J Mol Med 2004; 82: 467-476.
3. Poul MA, Marks JD. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 1999; 288: 203-211.
4. Kaiser AD. On the internal structure of bacteriophage lambda. J Gen Physiol 1966; 49: 171-178.
5. Zanghi CN, Lankes HA, Bradel-Tretheway B, Wegman J, Dewhurst S. A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda. Nucleic Acids Res 2005; 33: E160.
6. Baker ML, Jiang W, Rixon FJ, Chiu W. Common ancestry of herpesviruses and tailed DNA bacteriophage. J Virol 2005; 79: 14967-14970.
7. Larocca D, Jensen-Pergakes K, Burg MA, Baird A. Receptor-targeted gene delivery using multivalent phagemid particles. Mol Ther 2001; 3: 476-484.
8. Urbanelli L, Ronchini C, Fontana L, Menard S, Orlandi R, Monaci P. Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage. J Mol Biol 2001; 313: 965-976.
9. Larocca D, Witte A, Johnson W, Pierce GF, Baird A. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 1998; 9: 2393-2399.
10. Mount JD, Samoylova TI, Morrison NE, Cox NR, Baker HJ, Petrenko VA. Cell targeted phagemid rescued by preselected landscape phage. Gene 2004; 341: 59-65.
11. Ivanenkov VV, Felici F, Menon AG. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim Biophys Acta 1999; 1448: 463-472.
12. Li Z, Zhang J, Zhao R, Xu Y, Gu J. Preparation of peptide-targeted phagemid particles using a protein III-modified helper phage. Biotechniques 2005; 39: 493-497.
13. Banerjee D, Liu AP, Voss NR, Schmid SL, Finn MG. Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles. Chembiochem 2010; 11: 1273-1279.
14. Gupta A, Onda M, Pastan I, Adhya S, Chaudhary VK. High-density functional display of proteins on bacteriophage lambda. J Mol Biol 2003; 334: 241-254.
15. McCafferty J, Jackson RH, Chiswell DJ. Phage-enzymes: expression and affinity chromatography of functional alkaline phosphatase on the surface of bacteriophage. Protein Eng 1991; 4: 955-961.
16. Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol Pharm 2011; 8: 29-43.
17. Tong GJ, Hsiao SC, Carrico ZM, Francis MB. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J Am Chem Soc 2009; 131: 11174-11178.
18. Stephanopoulos N, Tong GJ, Hsiao SC, Francis MB. Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. ACS Nano 2010; 4: 6014-6020.
19. Wu W, Hsiao SC, Carrico ZM, Francis MB. Genome-Free viral capsids as multivalent carriers for Taxol delivery. Angew Chem Int Ed 2009; 48: 9493-9497.
20. Yacoby I, Bar H, Benhar I. Targeted drug-carrying bacteriophage as antibacterial nanomedicines. Antimicrob Agents Chemother 2007; 51: 2156-2163.
21. Yacoby I, Shamis M, Bar H, Shabat D, Benhar I. Targeting antibacterial agents by using drug-carrying filamentous bacteriophage. Antimicrob Agents Chemother 2006; 50: 2087-2097.
22. Singh P, Destito G, Schneemann A, Manchester M. Canine parvovirus-like particles, a novel nanomaterial for tumour targeting. J Nanobiotechnol 2006; 4: 2.
23. Sen Gupta S, Kuzelka J, Singh P, Lewis WG, Manchester M, Finn MG. Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. Bioconjug Chem 2005; 16: 1572-1579.
24. Destito G, Yeh R, Rae CS, Finn MG, Manchester M. Folic acid-mediated targeting of cowpea mosaic virus particles to tumour cells. Chem Biol 2007; 14: 1152-1162.
25. Zeng Q, Saha S, Lee LA, et al. Chemoselective modification of turnip yellow mosaic virus by Cu(I) catalysed azide-alkyne 1, 3-dipolar cycloaddition reaction and its application in cell binding. Bioconjug Chem 2011; 22: 58-66.
26. Ren Y, Wong SM, Lim LY. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem 2007; 18: 836-843.
27. Schlick TL, Ding Z, Kovacs EW, Francis MB. Dual surface modification of the tobacco mosaic virus. J Am Chem Soc 2005; 127: 3718-3723.
28. Banerjee PS, Ostapchuk P, Hearing P, Carrico I. Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells. J Am Chem Soc 2010; 132: 13615-13617.
29. Reddy JA, Clapp DW, Low PS. Retargeting of viral vectors to the folate receptor endocytic pathway. J Control Release 2001; 74: 77-82.
30. Ponnazhagan S, Mahendra G, Kumar S, Thompson JA, Castillas M Jr. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J Virol 2002; 76: 12900-12907.
31. Strable E, Prasuhn DE Jr, Udit AK, et al. Unnatural amino acid incorporation into virus-like particles. Bioconjug Chem 2008; 19: 866-875.
32. Huan RK, Steinmetz NF, Fu CY, Manchester M, Johnson JE. Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumour cells. Nanomedicine (Lond) 2011; 6: 55-68.
33. Li K, Chen Y, Li S, et al. Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjugate Chem 2010; 21: 1369-1377.
34. Wang J, Tian S, Petros RA, Napier ME, Desimone JM. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc 2010; 132: 11306-11313.
35. Khalaj-Kondori M, Sadeghizadeh M, Behmanesh M. Bacteriophage lambda-mediated gene transfer into human AGS cell line. Second International Conference on Chemical, Biological and Environmental Engineering (ICBEE). IEEE Xplore, New York, NY, USA, 2010; 176-179.
36. Nakase I, Lai H, Singh NP, Sasaki T. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 2008; 354: 28-33.
37. Lai H, Sasaki T, Singh NP, Messay A. Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci 2005; 76: 1267-1279.
38. Wagner E, Cotton M, Mechtler K, Kirlappos H, Birnstilel ML. DNA-binding transferrin conjugates as functional gene delivery agenets: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconjugate Chem 1991; 2: 226-231.
39. Fontana L, Nuzzo M, Urbanelli L, Monaci P. General strategy for broadening adenovirus tropism. J Virol 2003; 20: 11094-11104.
40. Volcy K, Dewhurst S. Proteasome inhibitors enhance bacteriophage lambda (λ) mediated gene transfer in mammalian cells. Virology 2009; 384: 77-87.
41. Ivanenkov VV, Felici F, Menon AG. Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim Biophys Acta 1999; 1448: 450-462.
42. Lankes HA, Zanghi CN, Santos K, Capella C, Duke CM, Dewhurst S. In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol 2007; 102: 1337-1349.
43. Zanghi CN, Sapinoro R, Bradel-Tretheway B, Dewhurst S. A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery. Nucleic Acids Res 2007; 35: E59.
44. Eguchi A, Akuta H, Senda T, et al. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 2001; 276: 26204-26210.
45. Swanson JA, Baer SC. Phagocytosis by zippers and triggers. Trends Cell Biol 1995; 5: 89-93.